Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

PURPOSE: Skeletal-related events (SREs) such as pathologic fracture, spinal cord compression, or the necessity for radiation or surgery to bone metastasis cause considerable morbidity, decrements in quality of life, and costs to the health care system. The results of a recent large randomized trial...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Oncol
Главные авторы: Shapiro, Charles L., Moriarty, James P., Dusetzina, Stacie, Himelstein, Andrew L., Foster, Jared C., Grubbs, Stephen S., Novotny, Paul J., Borah, Bijan J.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2017
Предметы:
ORIGINAL REPORTS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721226/
https://ncbi.nlm.nih.gov/pubmed/29023215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.7437
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы